Last reviewed · How we verify
Ocular gel
At a glance
| Generic name | Ocular gel |
|---|---|
| Also known as | No other intervention names |
| Sponsor | Sintetica SA |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Closed Versus Open Lateral Internal Sphincterotomy for Chronic Anal Fissure (NA)
- Cortical Electrophysiology of Response Inhibition in Parkinson's Disease (PHASE4)
- A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma (PHASE3)
- Physiological Investigations of Movement Disorders (NA)
- A Study Comparing Tretinoin Gel Microsphere, 0.04% and RETIN-A MICRO ® Gel Microsphere, 0.04% in the Treatment of Acne Vulgaris (PHASE1)
- Next Generation Personalized Neuroblastoma Therapy (PHASE1)
- Efficacy and Safety of Chloroprocaine 3% Gel and Oxybuprocaine 0.4% Eye Drops Anesthesia in Pediatric Population (PHASE3)
- Study Evaluating the Efficacy and Safety of Chloroprocaine HCl Ophthalmic Gel 3% vs Proparacaine Ophthalmic Solution 0.5% Plus Subconjunctival Lidocaine in Patients Undergoing Intravitreal Injections (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ocular gel CI brief — competitive landscape report
- Ocular gel updates RSS · CI watch RSS
- Sintetica SA portfolio CI